Pear Therapeutics, Inc. Warrant
PEARW
PEARW was delisted on the 18th of April, 2023.
45 hedge funds and large institutions have $8.62M invested in Pear Therapeutics, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 3 increasing their positions, reducing their positions, and 8 closing their positions.
785% more capital invested
Capital invested by funds: $974K → $8.62M (+$7.64M)
375% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 8
200% more funds holding
Funds holding: 15 → 45 (+30)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
+$427K |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$349K |
| 3 |
KCM
Kingstown Capital Management
New York
|
+$327K |
| 4 |
KC
Kepos Capital
New York
|
+$218K |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$201K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$150K |
| 3 |
OCM
Oribel Capital Management
New York
|
-$67K |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$48K |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
-$32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Goldman Sachs
New York
| – | -$13K | -13,180 | Closed |
|
|
DCM
52
DG Capital Management
New York
| – | -$8K | -8,333 | Closed |
|
|
CCM
53
Context Capital Management
Lajolla,
California
| – | +$175 | +200 | New |
|
PEARW Hedge Fund Activity: Q2 2021 in Review
45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q2 2021, worth a combined $8.62M — up 785% from $974K a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new PEARW positions and 8 closed out — a net gain of 30 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was P. Schoenfeld Asset Management (PSAM), opening a new position worth an estimated $427K. The largest seller was Saba Capital Management, exiting entirely with an estimated $201K sold.
- 45 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q2 2021, up from 15 in Q1 2021.
- Funds reported $8.62M of Pear Therapeutics, Inc. Warrant stock for Q2 2021, up 785% quarter-over-quarter.
- 38 funds opened new Pear Therapeutics, Inc. Warrant positions in Q2 2021 and 8 closed out, a net change of +30 holders.
- The largest Pear Therapeutics, Inc. Warrant buyer in Q2 2021 was P. Schoenfeld Asset Management (PSAM), an estimated $427K added.
- The largest Pear Therapeutics, Inc. Warrant seller in Q2 2021 was Saba Capital Management, an estimated $201K sold.
Based on aggregated 13F filings for Q2 2021.